Welcome to the Department of Pharmacological Sciences

Our mission is to provide excellence in biomedical research, graduate and undergraduate education. Our faculty bring in more than $10 million annually in direct extramural support, and exciting findings are reported regularly in a host of premier journals.

PROGRAMS:

Our Ph.D. program in Molecular and Cellular Pharmacology brings together gifted students, scientists and physicians from BNL, CSHL, and SBU striving to explore the biochemical and molecular biological mechanisms that regulate cell and organ function, and the design and development of effective pharmacological means to intervene in them when they are errant.

Our M.S. program in Biomedical Science, track Pharmacology provides a sound scientific foundation for students pursuing careers in the academic, pharmaceutical, and government sectors.

Undergraduate Studies in Pharmacology BCP 401/HBH 501/HBH 631 and BCP 402/HBH 502/HBH 632, which are required for most first-year graduate students (both Masters and PhD), are open to upper-level undergraduates as BCP 401 & 402.

More Upcoming Events

Department Newsletter

NEWS:

Congratulations to Maryam (Minnie) Azmi, PhD student in a Pharmacology lab for winning runner-up for the Stony Brook Three Minute Thesis Competition

Twelve Stony Brook graduate students took part in Stony Brook University’s annual Three Minute Thesis (3MT) competition on March 28. When the dust settled, Sai Abasolo, a doctoral candidate in biomedical engineering, was named the winner, having withstood competition that was at once enthusiastic, diverse and fierce.

Humble Beginnings Inspire Gary Matoren To Support Renaissance School of Medicine and Health Sciences Students

Difficult moments in people’s lives often are the catalyst to manifest positive things. Gary Matoren lost his daughter at the age of 9. Debbie Lynn was born with a heart defect he said was due to a drug his wife was prescribed for morning sickness. As a result, Gary dedicated his career to healthcare fields such as pharmacy, administration and clinical research. He is now creating a legacy at Stony Brook by leaving his estate to help graduate students continue their pursuit of researching and discovering ways to prevent genetic disorders.

SEMINAR/EVENTS: